Member Info for Thelix

Can't you amend that stop loss? This certainly seems to be dunking down to 6.5p and maybe even lower in the next couple of weeks.

Come on! .25 more drop and I'll pile in, you can do it OXP!

Yup, still waiting for my sub 7p re-entry though hehe. Late 6's were seen today but want a good 6.4-6.5p re-entry. I reckon we may see it soon then boom.

@ThePlunger (I have sid filtered but seems he initiated this? I can see him in the expanded reply view, thanks LSE admin!). I said longterm I am confident. My point is simply short term decline is certainly possible, and probable. Day traders love to buy on bad RNS as usually on AIM the drop is overdone. We see this here with the positive blip. Now we see the more realistic decline coming in as day traders moved out, and it becomes a more graduated decline in respect to doubt/nerves of holders. Until the next RNS, unless some very excitable buying occurs, it will slip somewhat. Longterm (6 Months+) I see this moving north of 8p easily. Actually read my post, rather than assuming because I said it will decline that I think it will decline forever and is a terrible investment. Why are so many people on LSE like this? They just read 1 part, and extrapolate and exxagerate to make out people are ramping/deramping, it is bizarre! I care little that Woodford is holding here, or at what price. When you have multiple millions/billions, piling in a few million to make up 0.3% of your portfolio is not very impressive. It's a nice marker to run alongside, but does not make the share infallible or an instant win. Rememeber - the formulation is the key here, NOT the drug, and the formulation failed to remove gastro side effects on the medical lanza scores - on naproxen. It may be different for Ibuprofen, but it is the formulation that is designed to stop the issue, not the drug, therefore I think short term there may be some panic or caution selling. However the company is confident, as am I looking at the data (as someone who works in this industry by the way!) that they will yield positive clinical trials. I just think for now, some slippage is probable - and has occurred over the last 2-3 trading days.

People bought in on the opportunistic dip. The excitement of that recovery is over and it is starting to tip back down. Long-term I am confident, but glad I got out @11/12p and also still looking for that 6p re-entry price. I might grumble into the 7's if I feel I may miss the boat, but otherwise, until the other news comes through (assuming it is positive) this may slip a little. How far depends on how many excitable buyers arrive for a bargain.

Lanza scores failed (won't require much to get them to pass, which is why there after statements stated they are confident they can get them to be statistically significant). Generally speaking pharmas go through these hurdles a lot, this is nothing new, having a failed clinical study - but as a pharma with no revenue, and requiring serious budgeting, more work and another trial needed to go forward means more cost, and more risk, and AIM mechanics will do this with gusto... Plus the company was valued north of £150 mil a few weeks back with no commercial product - quite high. This will recover. I am seeing this as an excellent buy in opportunity, but still think it may slip lower than 7p. 6p is my reentry target.

I sold most admittedly when I was in profit as I got in here sub 4p and sub 5p. when it was approx 10p (missed the 12 and 13!) I think this may slip a bit yes.

The wording is misleading though. In terms of erosions spotted - there is a statistically significant reduction. When translated into the medical Lanza score system across both the stomach and duodenum, it failed. But it does have good PK data and bioequivalence, and a reduction was had. They just need to apply it more aggressively, it only just failed!

Lanza scores did not meet statistically significant endpoint. The Lanza score is what gets the product out unfortunately. More work needed.

the formulation, not the drug. If the formulation does not ease intestinal and abdominal swelling/ulceration as many NSAID's do, then it doesn't matter if you use it with naproxen or ibuprofen. I highly doubt the results are bad, and if they are - then the formulation is the issue, not the drug, meaning ibuprofen will be bad too. This is simply AIM mechanics where the price gets to the placing price - it pretty much always happens even when it's a tiny %. Plus AIM overall has been taking a hammering. Many companies fastforward projects to save money. OXP isn't a huge biotech that can throw money everywhere. It has to strategise each part of its implementation.

but medium term I can see 20p on the Horizon. and longterm 50p. Only thing holding this back is results. On positive results this will hit 20p fairly quickly. Bad results it will fall, but isn't that any company listed on any market? There is always a downside. Simply look at the upside, and the fact OXP have had excellent trial results so far, giving large confidence for future tougher trials. It's when earlier trials just stretch out a pass that the later in depth ones are a bit shaky.

10p placing - this should be the resistance point. Time for top up or re-entry IMPO. If it falls below the 10p placing resistance I am going to buy these like they're candy.

on AIM, no matter how small the placing, or the upside, the price always nearly reaches it. Probably get some nice buy ins at 10.5p. May go lower than that even. But it will shoot up soon after. Just consider it a nice top up zone, or re entry zone. Must admit sold some here already as tripled money nearly.

This convertible loan. essentially it's a period which receives cash for dilution no? Like Darwin and Bergen? It's just, every other time I see a company take out one of these kinds of loans (SAV, FTE being some of the ones I have invested in the past) the SP tanked. Is something different here?

Shhhh! The spikees need their money back and are willing to use any tactic to begin a flurry of buying for a 2nd spike to sell on. Saying this, I am sure this will yo-yo for a while. I will be staying out of this one - I enjoy my heart health.

Friday. Have been monitoring this ever since. Looks like a good time to top up soon - but may wait to see what tomorrow brings.

Bought in this morning. Think I shall sell on the 50% high.

Tends to drop fast, especially on AIM, and especially mining companies. The fact this had all 3, is kind of obvious. Please see MSMN, ROSE, TRP, LOND, SAV, ALO, etc etc to see the same spike patterns. Still, A nice buying point for me tomorrow. I can't see it dipping much beyond the original starting price before the spike (1.4p vs 1.55p) with such a great RNS. To those who bought in high - lower averaged if you believe in the company, or get ready to do the holding dance. Do not sell. If it tanks it tanks. Always game what you're willing to lose. Look at AIM as a bet, like any other bet you lose you entire stake. So bet accordingly. It makes loss easier to bear, and also means holding is less painful, as even 50% of your holding is better than 0%.

Amazing what herd buying can do in AIM eh? I'd definitely sell now if I got in anything below 3p lol. Might go 20p again, and you miss out on 1000% profit, but might go to 0.2p and lost it all. Nobody can sell out on top all the time. Made a profit? Sell it and enjoy, and don't look back at the rising SP lol

But fantastic rise. Would love to put some in here but scared of getting spiked ala AIM fast risers (not a deramp, just statistcal likelihood with AIM shares). Congratulations to all who have made plenty of money! Hope you have a lavish Christmas this year!